Moreover, IGFBP2 was significantly upregulated in human CTNNB1;MYC-mutated HCC as well as end point Ctnnb1ex3/WT;R26LSL-MYC mouse liver tumours (Fig. 1n and Extended Data Fig. 2a–c). This evidence concerns the gene CTNNB1 and hepatocellular carcinoma.